Marshall Wace
AWH

Marshall Wace’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Marshall Wace’s Portfolio AWH Stock Details AWH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,120
Closed -$298K – 4391
2021
Q3 		$298K Buy
+6,120
New +$378K ﹤0.01% 2649

Other funds holding AWH

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Marshall Wace's AWH Position: Q4 2021 in Review

Marshall Wace sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2021, closing a stake of 6,120 shares — an estimated $298K sold.

Marshall Wace first reported a position in AWH in Q3 2021 and held it in 1 quarter. The position peaked at $298K in Q3 2021. 98 funds tracked by Wall St. Rank hold AWH as of Q4 2021.

  • Marshall Wace reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Marshall Wace sold 6,120 Aspira Women's Health Inc. Common Stock shares in Q4 2021, an estimated $298K.
  • Marshall Wace first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Marshall Wace's Aspira Women's Health Inc. Common Stock position peaked at $298K in Q3 2021.
  • 98 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2021.

Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.